Clinical trial / 2003
Soy protein supplementation reduced bone resorption and increased IGF-I more than milk protein in postmenopausal women, especially those not on HRT.
Postmenopausal women were randomly assigned to consume 40 g daily of either soy protein (SP) or milk-based protein (MBP) for 3 months. Both supplements increased serum IGF-I, but SP had a more pronounced effect than MBP, with the greatest impact (a 97% increase) seen in women not on HRT. Urinary Dpd excretion was significantly reduced by SP, but not MBP, driven by changes in women not on HRT. In addition, MBP led to a 33% increase in urinary calcium excretion, whereas SP did not.
- Study type
- Double-blind, randomized, parallel-group trial
- Who was studied
- 71 postmenopausal women randomly assigned; 42 completed (20 on soy protein, 22 on milk-based protein)
- What was measured
- Serum IGF-I, urinary deoxypyridinoline (Dpd) excretion, and urinary calcium excretion
THE PAPER
Soy protein has a greater effect on bone in postmenopausal women not on hormone replacement therapy, as evidenced by reducing bone resorption and urinary calcium excretion.
Arjmandi BH, Khalil DA, Smith BJ, Lucas EA, Juma S, Payton ME, Wild RA. J Clin Endocrinol Metab, 2003.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.